SCHEMBL5175386

SCHEMBL5175386

c1cncc(C2C3CC[N@](C3)C23CCNC3)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 8/20 0.40
CHRNA4 P43681 8/20 0.40
CHRNA7 P36544 7/20 0.38
MEN1 O00255 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2A6 P11509 2/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CHRNB4 P30926 4/20 0.37
CHRNA3 P32297 4/20 0.37
CHRNA1 P02708 2/20 0.37
CHRNG P07510 2/20 0.37
CHRNB1 P11230 2/20 0.37
CHRND Q07001 2/20 0.37
CHRNA2 Q15822 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5174223 0.99 CHRNB2 (0.40) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL5173137 0.93 CHRNB2 (0.42) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL5175204 0.85 CHRNB2 (0.33) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL5173061 0.80 CHRNB2 (0.39) CHRNB2CHRNA4CHRNA7MEN1KMT2A
SCHEMBL5174771 0.80 CHRM2 (0.32)
SCHEMBL5171662 0.79 SLC6A2 (0.36) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL5172835 0.77 CHRNA3 (0.40) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL5175183 0.75 CHRNB2 (0.42) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB3
SCHEMBL5172471 0.75
SCHEMBL5173067 0.72 CHRNB2 (0.40) CHRNB2CHRNA4CHRNA7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784184-A2 THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION Targacept, Inc. (US) 2007-05-16 EP claimed
WO-2006023630-A2 THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION TARGACEPT, INC. (US) 2006-03-02 WO claimed